Our Immunosuppression Pathogen portfolio offers sensitive and reliable molecular diagnostic solutions for the detection and monitoring of opportunistic viral infections in immunocompromised patients. Covering clinically significant targets such as Human Herpes Virus (HHV-8), Human Parvovirus B19, Epstein-Barr Virus (EBV), Human Herpes Virus (HHV-6), Varicella Zoster Virus (VZV), and quantitative Human Cytomegalovirus (HCMV), these Real-Time PCR assays are designed to deliver high sensitivity, specificity, and consistent performance.

With accurate results and efficient workflow integration, our kits help laboratories support early diagnosis, patient monitoring, and informed clinical decision-making in transplant care, oncology, and other immunosuppressed settings.